{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:57:20Z","timestamp":1792612640438,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vestre Viken Hospital Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The separate effects of systolic (SBP) and diastolic blood pressure (DBP) on cerebral small vessel disease (cSVD) development needs elucidation. We investigated the association between SBP and DBP at age 40 and two selected brain magnetic resonance imaging (MRI) features of cSVD (lacunes and white matter hyperintensities [WMHs]) at age 70 in a general Norwegian population cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We included individuals from the Akershus Cardiac Examination (ACE) 1950 Study (2012\u20132015) who had previously participated in the Age 40 Program (1990\u20131993).<\/jats:p>\n            <jats:p>A random subset of participants with SBP in the categories of non-elevated (&lt;\u2009120 mmHg), high elevated (130\u2013139 mmHg) or hypertension (\u2265\u2009140 mmHg) at age 40 were invited to perform brain MRI for assessment of cSVD (lacunes and WMHs) at age 70 (2016\u20132024). DBP was categorized as non-elevated (&lt;\u200970 mmHg), low elevated (70\u201379 mmHg), high elevated (80\u201389 mmHg) and hypertension (\u2265\u200990 mmHg). Logistic and ordinal regressions assessed the association between SBP and DBP and lacunes and severity of WMHs (measured with Fazekas scale), adjusting for sex, total cholesterol, smoking, physical activity, diabetes, education, and age at MRI, with non-elevated BP as the reference category.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 414 participants (167 [40%] women) were included. Participants were 70.2\u2009\u00b1\u20092.3 years when undergoing brain MRI. Mean Fazekas scale was 1.3\u2009\u00b1\u20090.8, and 54 (13%) had lacunes. SBP and DPB were not associated with lacunes. DPB of 80\u201389 mmHg (adjusted OR [95% CI], 1.91 [1.01\u20133.62]) and\u2009\u2265\u200990 mmHg (2.11 [1.06\u20134.19]) at age 40 were associated with WMHs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Elevated DBP (80\u201389 mmHg) and diastolic hypertension (&gt;\u200990 mmHg) at age 40 were associated with WMH burden at age 70, suggesting a long-term association between midlife DBP and cerebrovascular health.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov. NCT01555411. 15 March 2012.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n            <jats:p>Figure developed by the authors using venngage.com with a license to use, reproduce and distribute worldwide. ACE, Akershus Cardiac Examination. BP, blood pressure. DBP, diastolic blood pressure. MRI, magnetic resonance imaging. WMHs, white matter hyperintensities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12872-025-05140-6","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:59:05Z","timestamp":1759989545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood pressure at age 40 and key features of cerebral small vessel disease at age 70: data from the ACE 1950 Study"],"prefix":"10.1186","volume":"25","author":[{"given":"Marte M.","family":"Walle-Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guri","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Myrstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Vigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Ihle-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Thommessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Ariansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus N.","family":"Lyngbakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"R\u00f8sj\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole M.","family":"R\u00f8nning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona K.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnljot","family":"Tveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kon","family":"Ihle-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"4","key":"5140_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/awf077","volume":"125","author":"FE de Leeuw","year":"2002","unstructured":"de Leeuw FE, de Groot JC, Oudkerk M, Witteman JCM, Hofman A, van Gijn J, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002;125(4):765\u201372.","journal-title":"Brain"},{"issue":"2","key":"5140_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.STR.0000052631.98405.15","volume":"34","author":"SE Vermeer","year":"2003","unstructured":"Vermeer SE, den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MMB. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34(2):392\u20136.","journal-title":"Stroke"},{"issue":"2","key":"5140_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1161\/01.STR.25.2.318","volume":"25","author":"TA Manolio","year":"1994","unstructured":"Manolio TA, Kronmal RA, Burke GL, Poirier V, O\u2019Leary DH, Gardin JM, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 1994;25(2):318\u201327.","journal-title":"Stroke"},{"issue":"2","key":"5140_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P","volume":"47","author":"JC de Groot","year":"2000","unstructured":"de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47(2):145\u201351.","journal-title":"Ann Neurol"},{"issue":"10","key":"5140_CR5","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1161\/01.STR.0000179092.59909.42","volume":"36","author":"WM van der Flier","year":"2005","unstructured":"van der Flier WM, van Straaten ECW, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly. Stroke. 2005;36(10):2116\u201320.","journal-title":"Stroke"},{"issue":"10","key":"5140_CR6","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1161\/01.STR.0000032241.58727.49","volume":"33","author":"WT Longstreth Jr","year":"2002","unstructured":"Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O\u2019Leary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2002;33(10):2376\u201382.","journal-title":"Stroke"},{"issue":"1","key":"5140_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/01.STR.0000149625.99732.69","volume":"36","author":"WT Longstreth Jr","year":"2005","unstructured":"Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2005;36(1):56\u201361.","journal-title":"Stroke"},{"issue":"4","key":"5140_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/STROKEAHA.109.570044","volume":"41","author":"S Debette","year":"2010","unstructured":"Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham offspring study. Stroke. 2010;41(4):600\u20136.","journal-title":"Stroke"},{"key":"5140_CR9","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"issue":"7","key":"5140_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","volume":"6","author":"SE Vermeer","year":"2007","unstructured":"Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611\u20139.","journal-title":"Lancet Neurol"},{"issue":"13","key":"5140_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215\u201322.","journal-title":"N Engl J Med"},{"issue":"7","key":"5140_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw F-E, et al. Neuroimaging standards for research into small vessel disease\u2014advances since 2013. Lancet Neurol. 2023;22(7):602\u201318.","journal-title":"Lancet Neurol"},{"issue":"1","key":"5140_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/17474930221144911","volume":"18","author":"HS Markus","year":"2023","unstructured":"Markus HS, de Leeuw FE. Cerebral small vessel disease: Recent advances and future directions. Int J Stroke. 2023;18(1):4\u201314.","journal-title":"Int J Stroke"},{"issue":"24","key":"5140_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","volume":"92","author":"RJ Cannistraro","year":"2019","unstructured":"Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: a clinical review. Neurology. 2019;92(24):1146\u201356.","journal-title":"Neurology"},{"issue":"7","key":"5140_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/eurheartj\/ehaa756","volume":"42","author":"KA Wartolowska","year":"2021","unstructured":"Wartolowska KA, Webb AJS. Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study. Eur Heart J. 2021;42(7):750\u20137.","journal-title":"Eur Heart J"},{"issue":"1","key":"5140_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/STROKEAHA.109.566992","volume":"41","author":"RF Gottesman","year":"2010","unstructured":"Gottesman RF, Coresh J, Catellier DJ, Sharrett AR, Rose KM, Coker LH, et al. Blood pressure and white-matter disease progression in a biethnic cohort. Stroke. 2010;41(1):3\u20138.","journal-title":"Stroke"},{"issue":"7","key":"5140_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/WNL.56.7.921","volume":"56","author":"C Dufouil","year":"2001","unstructured":"Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001;56(7):921\u20136.","journal-title":"Neurology"},{"issue":"12","key":"5140_CR18","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/01.STR.27.12.2262","volume":"27","author":"D Liao","year":"1996","unstructured":"Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. Stroke. 1996;27(12):2262\u201370.","journal-title":"Stroke"},{"issue":"38","key":"5140_CR19","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"6","key":"5140_CR20","first-page":"308","volume":"49","author":"T Berge","year":"2015","unstructured":"Berge T, Vigen T, Pervez MO, Ihle-Hansen H, Lyngbakken MN, Omland T, et al. Heart and brain interactions\u2013the akershus cardiac examination (ACE) 1950 study design. Scand Cardiovasc J. 2015;49(6):308\u201315.","journal-title":"Scand Cardiovasc J"},{"issue":"7","key":"5140_CR21","doi-asserted-by":"publisher","first-page":"e021704","DOI":"10.1136\/bmjopen-2018-021704","volume":"8","author":"T Berge","year":"2018","unstructured":"Berge T, Lyngbakken MN, Ihle-Hansen H, Brynildsen J, Pervez MO, Aagaard EN, et al. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63\u201365 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study. BMJ Open. 2018;8(7):e021704.","journal-title":"BMJ Open"},{"issue":"22","key":"5140_CR22","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1093\/eurheartj\/ehn435","volume":"29","author":"A Tverdal","year":"2008","unstructured":"Tverdal A, Hjellvik V, Selmer R. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379 843 men and women aged 40\u201345 years. Eur Heart J. 2008;29(22):2772\u201381.","journal-title":"Eur Heart J"},{"issue":"1","key":"5140_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000341859","volume":"40","author":"MdC Vald\u00e9s Hern\u00e1ndez","year":"2012","unstructured":"Vald\u00e9s Hern\u00e1ndez MdC, Morris Z, Dickie DA, Royle NA, Mu\u00f1oz Maniega S, Aribisala BS, et al. Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology. 2012;40(1):13\u201322.","journal-title":"Neuroepidemiology"},{"issue":"1\u20132","key":"5140_CR24","first-page":"51","volume":"24","author":"L Pantoni","year":"2004","unstructured":"Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, et al. Impact of age-related cerebral white matter changes on the transition to disability \u2013 the LADIS study: rationale, design and methodology. Neuroepidemiology. 2004;24(1\u20132):51\u201362.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"5140_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamaneurol.2018.3122","volume":"76","author":"S Debette","year":"2019","unstructured":"Debette S, Schilling S, Duperron M-G, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76(1):81\u201394.","journal-title":"JAMA Neurol"},{"issue":"S4","key":"5140_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/sms.12611","volume":"25","author":"G Grimby","year":"2015","unstructured":"Grimby G, B\u00f6rjesson M, Jonsdottir IH, Schnohr P, Thelle DS, Saltin B. The, \u201cSaltin\u2013Grimby Physical Activity Level Scale\u201d and its application to health research. Scand J Med Sci Sports. 2015;25(S4):119\u201325.","journal-title":"Scand J Med Sci Sports"},{"issue":"8","key":"5140_CR27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1177\/1747493020984090","volume":"16","author":"TRJ Landman","year":"2021","unstructured":"Landman TRJ, Thijssen DHJ, Tuladhar AM, de Leeuw F-E. Relation between physical activity and cerebral small vessel disease: a nine-year prospective cohort study. Int J Stroke. 2021;16(8):962\u201371.","journal-title":"Int J Stroke"},{"issue":"4","key":"5140_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/STROKEAHA.123.044173","volume":"55","author":"E Dao","year":"2024","unstructured":"Dao E, Barha CK, Zou J, Wei N, Liu-Ambrose T. Prevention of vascular contributions to cognitive impairment and dementia: the role of physical activity and exercise. Stroke. 2024;55(4):812\u201321.","journal-title":"Stroke"},{"issue":"10","key":"5140_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(19)30228-5","volume":"18","author":"CA Lane","year":"2019","unstructured":"Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019;18(10):942\u201352.","journal-title":"Lancet Neurol"},{"issue":"2","key":"5140_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/STROKEAHA.119.025139","volume":"51","author":"MR Caunca","year":"2020","unstructured":"Caunca MR, Simonetto M, Cheung YK, Alperin N, Lee SH, Elkind MSV, et al. Diastolic blood pressure is associated with regional white matter lesion load: the Northern Manhattan Study. Stroke. 2020;51(2):372\u20138.","journal-title":"Stroke"},{"issue":"9","key":"5140_CR31","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1161\/STROKEAHA.111.617571","volume":"42","author":"J Marcus","year":"2011","unstructured":"Marcus J, Gardener H, Rundek T, Elkind MSV, Sacco RL, DeCarli C, et al. Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume. Stroke. 2011;42(9):2639\u201341.","journal-title":"Stroke"},{"issue":"1","key":"5140_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ageing\/afx102","volume":"47","author":"CJ McNeil","year":"2018","unstructured":"McNeil CJ, Myint PK, Sandu AL, Potter JF, Staff R, Whalley LJ, et al. Increased diastolic blood pressure is associated with MRI biomarkers of dementia-related brain pathology in normative ageing. Age Ageing. 2018;47(1):95\u2013100.","journal-title":"Age Ageing"},{"issue":"12","key":"5140_CR33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/ajh\/hpy104","volume":"31","author":"M Shokouhi","year":"2018","unstructured":"Shokouhi M, Qiu D, Samman Tahhan A, Quyyumi AA, Hajjar I. Differential associations of diastolic and systolic pressures with cerebral measures in older individuals with mild cognitive impairment. Am J Hypertens. 2018;31(12):1268\u201377.","journal-title":"Am J Hypertens"},{"issue":"15","key":"5140_CR34","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","volume":"283","author":"The AO, Coordinators for the ACRG","year":"2000","unstructured":"The AO, Coordinators for the ACRG. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidonethe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283(15):1967\u201375.","journal-title":"JAMA."},{"issue":"23","key":"5140_CR35","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The AO, Coordinators for the ACRG","year":"2002","unstructured":"The AO, Coordinators for the ACRG. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981\u201397.","journal-title":"JAMA."},{"key":"5140_CR36","doi-asserted-by":"crossref","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","DOI":"10.1056\/NEJMoa1511939"},{"issue":"6","key":"5140_CR37","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13\u2013115.","journal-title":"Hypertension"},{"issue":"6","key":"5140_CR38","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/HYPERTENSIONAHA.111.00430","volume":"61","author":"BFJ Verhaaren","year":"2013","unstructured":"Verhaaren BFJ, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013;61(6):1354\u20139.","journal-title":"Hypertension"},{"issue":"6","key":"5140_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H","volume":"46","author":"FE de Leeuw","year":"1999","unstructured":"de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol. 1999;46(6):827\u201333.","journal-title":"Ann Neurol"},{"issue":"5","key":"5140_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/01.HYP.0000145857.98904.20","volume":"44","author":"EJ van Dijk","year":"2004","unstructured":"van Dijk EJ, Breteler MMB, Schmidt R, Berger K, Nilsson L-G, Oudkerk M, et al. The association between blood pressure, hypertension, and cerebral white matter lesions. Hypertension. 2004;44(5):625\u201330.","journal-title":"Hypertension"},{"issue":"8","key":"5140_CR41","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"2","key":"5140_CR42","doi-asserted-by":"publisher","first-page":"CXI","DOI":"10.1177\/23969873211012132","volume":"6","author":"JM Wardlaw","year":"2021","unstructured":"Wardlaw JM, Debette S, Jokinen H, De Leeuw F-E, Pantoni L, Chabriat H, et al. ESO guideline on covert cerebral small vessel disease. Eur Stroke J. 2021;6(2):CXI\u2013CLXII.","journal-title":"Eur Stroke J"},{"issue":"7","key":"5140_CR43","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/STROKEAHA.122.040444","volume":"54","author":"AE Bilski","year":"2023","unstructured":"Bilski AE, Aparicio HJ, Gutierrez J, de Leeuw F-E, Hilkens NA. Antiplatelet therapy or not for asymptomatic\/incidental lacunar infarction. Stroke. 2023;54(7):1954\u20139.","journal-title":"Stroke"},{"issue":"6","key":"5140_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/ene.14196","volume":"27","author":"AH Katsanos","year":"2020","unstructured":"Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, et al. Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta-analysis of randomized trials. Eur J Neurol. 2020;27(6):1023\u20137.","journal-title":"Eur J Neurol"},{"issue":"2","key":"5140_CR45","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","volume":"48","author":"EE Smith","year":"2017","unstructured":"Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2017;48(2):e44\u201371.","journal-title":"Stroke"},{"issue":"3\u20134","key":"5140_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000441420","volume":"16","author":"C Boutet","year":"2016","unstructured":"Boutet C, Rouffiange-Leclair L, Schneider F, Camdessanch\u00e9 JP, Antoine JC, Barral FG. Visual assessment of age-related white matter hyperintensities using FLAIR images at 3 T: inter- and intra-rater agreement. Neurodegener Dis. 2016;16(3\u20134):279\u201383.","journal-title":"Neurodegener Dis"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05140-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:05:27Z","timestamp":1759993527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05140-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5140"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05140-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ACE 1950 Study has been approved by the Regional Committee for Medical and Health Research Ethics in Norway (reference number 2011\/1475). The study is preregistered and adheres to the Declaration of Helsinki. An informed consent was signed by all participants who enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.M. has received lecture fees from AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, MSD, and Pfizer. For the remaining authors none were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"724"}}